GO
Loading...

Celgene Corp

More

  • Midday Glance: Biotechnology companies Friday, 31 Oct 2014 | 2:49 PM ET

    Amgen Inc. rose $2.12 or 1.3 percent, to $163.70. Biogen Idec rose $1.73 or. 5 percent, to $322.73. Celgene Corp. rose $1.05 or 1.0 percent, to $107.99.

  • Early Glance: Biotechnology companies Friday, 31 Oct 2014 | 12:28 PM ET

    Amgen Inc. rose $1.59 or 1.0 percent, to $163.17. Biogen Idec rose $5.81 or 1.8 percent, to $326.81. Celgene Corp. rose $1.28 or 1.2 percent, to $108.22.

  • Final Glance: Biotechnology companies Thursday, 30 Oct 2014 | 6:02 PM ET

    Amgen Inc. rose $2.70 or 1.7 percent, to $161.58. Biogen Idec rose $5.94 or 1.9 percent, to $321.00. Celgene Corp. rose $1.80 or 1.7 percent, to $106.94.

  • Midday Glance: Biotechnology companies Thursday, 30 Oct 2014 | 1:17 PM ET

    Amgen Inc. rose $1.58 or 1.0 percent, to $160.46. Biogen Idec rose $7.39 or 2.3 percent, to $322.45. Celgene Corp. rose $1.80 or 1.7 percent, to $106.94.

  • Early Glance: Biotechnology companies Thursday, 30 Oct 2014 | 11:28 AM ET

    Amgen Inc. fell$. 40 or. 3 percent, to $158.48. Biogen Idec rose$. 43 or. 1 percent, to $315.49. Celgene Corp. fell$. 35 or. 3 percent, to $104.79.

  • Final Glance: Biotechnology companies Wednesday, 29 Oct 2014 | 6:02 PM ET

    Amgen Inc. rose $1.69 or 1.1 percent, to $158.88. Biogen Idec fell $2.97 or. 9 percent, to $315.06. Celgene Corp. fell$. 56 or. 5 percent, to $105.14.

  • Midday Glance: Biotechnology companies Wednesday, 29 Oct 2014 | 1:41 PM ET

    Amgen Inc. rose $1.86 or 1.2 percent, to $159.05. Biogen Idec fell $3.36 or 1.1 percent, to $314.67. Celgene Corp. fell$. 67 or. 6 percent, to $105.03.

  • Early Glance: Biotechnology companies Wednesday, 29 Oct 2014 | 10:53 AM ET

    Amgen Inc. rose$. 90 or. 6 percent, to $158.09. Biogen Idec rose $1.09 or. 3 percent, to $319.12. Celgene Corp. rose$. 43 or. 4 percent, to $106.13.

  • Final Glance: Biotechnology companies Tuesday, 28 Oct 2014 | 6:14 PM ET

    Amgen Inc. rose $8.99 or 6.1 percent, to $157.19. Biogen Idec fell $1.95 or. 6 percent, to $318.03. Celgene Corp. rose $2.60 or 2.5 percent, to $105.70.

  • Midday Glance: Biotechnology companies Tuesday, 28 Oct 2014 | 1:25 PM ET

    Amgen Inc. rose $7.24 or 4.9 percent, to $155.44. Biogen Idec fell $3.28 or 1.0 percent, to $316.70. Celgene Corp. rose $2.18 or 2.1 percent, to $105.28.

  • Early Glance: Biotechnology companies Tuesday, 28 Oct 2014 | 10:31 AM ET

    Amgen Inc. rose $6.60 or 4.5 percent, to $154.80. Biogen Idec fell $1.10 or. 3 percent, to $318.88. Celgene Corp. rose $2.18 or 2.1 percent, to $105.28.

  • Final Glance: Biotechnology companies Monday, 27 Oct 2014 | 6:06 PM ET

    Amgen Inc. rose$. 94 or. 6 percent, to $148.20. Biogen Idec fell $1.69 or. 5 percent, to $319.98. Celgene Corp. fell$. 14 or. 1 percent, to $103.10.

  • Oct 27- Amgen Inc on Monday reported higher-than-expected third quarter profit and revenue, helped by strong demand for its white blood cell booster, Neulasta, and increased sales of newer drugs, and the company raised its full-year forecast. Amgen shares are up almost 20 percent since the restructuring announcement that involved plant closings and the...

  • Midday Glance: Biotechnology companies Monday, 27 Oct 2014 | 1:17 PM ET

    Amgen Inc. rose$. 57 or. 4 percent, to $147.83. Biogen Idec fell $2.92 or. 9 percent, to $318.75. Celgene Corp. fell$. 19 or. 2 percent, to $103.05.

  • Early Glance: Biotechnology companies Monday, 27 Oct 2014 | 10:40 AM ET

    Amgen Inc. fell$. 07 or percent, to $147.19. Biogen Idec fell $3.44 or 1.1 percent, to $318.23. Celgene Corp. fell$. 47 or. 5 percent, to $102.77.

  • Final Glance: Biotechnology companies Friday, 24 Oct 2014 | 6:35 PM ET

    Amgen Inc. rose$. 01 or percent, to $147.26. Biogen Idec rose $5.61 or 1.8 percent, to $321.67. Celgene Corp. rose $2.84 or 2.8 percent, to $103.24.

  • Oct 24- Amgen Inc, one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund. In a letter to investors on Tuesday, Loeb said Amgen has "all the hallmarks of a hidden value situation" and should divide...

  • Midday Glance: Biotechnology companies Friday, 24 Oct 2014 | 1:17 PM ET

    Amgen Inc. fell $1.41 or 1.0 percent, to $145.84. Biogen Idec rose $3.09 or 1.0 percent, to $319.15. Celgene Corp. rose $2.15 or 2.1 percent, to $102.55.

  • Early Glance: Biotechnology companies Friday, 24 Oct 2014 | 10:40 AM ET

    Amgen Inc. fell$. 43 or. 3 percent, to $146.82. Biogen Idec rose $1.58 or. 5 percent, to $317.64. Celgene Corp. rose $1.93 or 1.9 percent, to $102.33.

  • Final Glance: Biotechnology companies Thursday, 23 Oct 2014 | 6:02 PM ET

    Amgen Inc. rose $3.61 or 2.5 percent, to $147.25. Biogen Idec rose $6.99 or 2.3 percent, to $316.06. Celgene Corp. rose $5.64 or 6.0 percent, to $100.40.